Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-26.65	6.52	8.88
Graham Fair Price	16.94	5.04	4.31
PEG	182.03	0.13	-0.05
Price/Book	-31.54	0.63	0.92
Price/Cash Flow	-63.56	3.07	8.42
Prices/Earnings	-43.92	4.11	7.33
Price/Sales	-11.27	0.69	0.78
Price/FCF	-63.56	3.07	8.42
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-2.55	0.06	0.07
Operating Margin	2.25	0.06	0.06
ROA	29.76	0.01	< 0.005
ROE	0.03	0.04	22.06
ROIC	0.03	0.02	-41.39
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.13	94.40
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	2.42	-0.17	-93.17
EPS QOQ	1.57	0.31	-80.11
FCF QOQ	9.30	0.99	-89.38
Revenue QOQ	0.24	-0.18	-24.97
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	2.02	2.12	4.91
Days Sales Outstanding (DSO)	69.77	69.61	-0.22
Inventory Turnover	44.59	42.50	-4.68
Debt/Capitalization	0.43	0.54	24.80
Quick Ratio	1.09	1.16	6.76
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5.13	5.43	5.84
Cash	4.35	5.36	23.11
Capex	-0.24	-0.07	71.52
Free Cash Flow	0.56	1.11	98.84
Revenue	6.07	4.95	-18.34
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.10	1.17	6.53
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.74	1.53	-44.10
Naive Interpretation	Member

06 - Financial Health · Bad

Rating